Evidence map›Paper›PMID 26405110›Full record

ArticleJournal of the American Society of Nephrology : JASN2016

Apheresis to Treat Preeclampsia: Insights, Opportunities and Challenges.

Thomas R Easterling

Registry-linked trialOpen access · bronzeAbstract readEditorialComment
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01404910 (Phase 1b Proof-of-Concept Study of Apheresis to Reduce Soluble Fms-like Tyrosine Kinase-1), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01404910 nacompletednot on this map

Phase 1b Proof-of-Concept Study of Apheresis to Reduce Soluble Fms-like Tyrosine Kinase-1 (sFlt-1) in Pregnant Women With Preeclampsia Using a Dextran Sulfate Adsorption (DSA) Column (LIPOSORBER® LA-15 System)

TypeinterventionalSponsorMassachusetts General HospitalRan2013 to 2015Enrolled11ConditionsPreeclampsiaArmsApheresis using Liposorber LA-15 System
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Thomas R EasterlingDepartment of Obstetrics and Gynecology, University of Washington, Seattle, Washington easter@uw.edu.
University of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Birth WeightBlood Component RemovalDextran SulfateFemaleHumansPre-EclampsiaPregnancyVascular Endothelial Growth Factor Receptor-1Dextran SulfateVascular Endothelial Growth Factor Receptor-1preeclampsiasFlt-1VEGF

Identifiers

PMID26405110
PMCPMC4769212
OpenAlexW2176212302

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.